Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesis
Authors:
- Philip T. MurphyPMPhilip T. Murphy
- Suzanne McPhersonSMSuzanne McPherson
- Karen BreenKBKaren Breen
- Jiri SlabyJSJiri Slaby
- 1 January 2009
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 50 (6) , 1036-1038
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Myelodysplastic syndromesBlood, 2008
- Efficacy and Safety of Erythropoiesis-Stimulating Proteins in Myelodysplastic Syndrome: A Systematic Review and Meta-AnalysisThe Oncologist, 2007
- Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiencyAnnals of Hematology, 2006
- The myelodysplastic syndrome(s): a perspective and review highlighting current controversiesLeukemia Research, 2003
- Zinc porphyrins: Potent inhibitors of hematopoieses in animal and human bone marrowProceedings of the National Academy of Sciences, 1997